Efficacy and safety of ceftazidime–avibactam versus polymyxins in the treatment of carbapenem-resistant Enterobacteriaceae infection: a systematic review and meta-analysis

OBJECTIVES: Carbapenem-resistant Enterobacteriaceae is increasingly recognised as a significant public health concern. Ceftazidime-avibactam (CAZ-AVI) and polymyxins are considered as the last therapeutic options worldwide. This is the first meta-analysis of recently published data to compare the cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ping, Li, Yinyan, Wang, Xiaojuan, Chen, Na, Lu, Xiaoyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163451/
https://www.ncbi.nlm.nih.gov/pubmed/37137556
http://dx.doi.org/10.1136/bmjopen-2022-070491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163451/
https://www.ncbi.nlm.nih.gov/pubmed/37137556
http://dx.doi.org/10.1136/bmjopen-2022-070491

Ejemplares similares